Copyright Reports & Markets. All rights reserved.

Global Fesoterodine Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Fesoterodine Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 4 mg Tablet
      • 1.4.3 8 mg Tablet
    • 1.5 Market by Application
      • 1.5.1 Global Fesoterodine Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Drug store
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Fesoterodine Market Size
    • 2.2 Fesoterodine Growth Trends by Regions
      • 2.2.1 Fesoterodine Market Size by Regions (2014-2025)
      • 2.2.2 Fesoterodine Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Fesoterodine Market Size by Manufacturers
      • 3.1.1 Global Fesoterodine Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Fesoterodine Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Fesoterodine Market Concentration Ratio (CR5 and HHI)
    • 3.2 Fesoterodine Key Players Head office and Area Served
    • 3.3 Key Players Fesoterodine Product/Solution/Service
    • 3.4 Date of Enter into Fesoterodine Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Fesoterodine Market Size by Type (2014-2019)
    • 4.2 Global Fesoterodine Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Fesoterodine Market Size (2014-2019)
    • 5.2 Fesoterodine Key Players in United States
    • 5.3 United States Fesoterodine Market Size by Type
    • 5.4 United States Fesoterodine Market Size by Application

    6 Europe

    • 6.1 Europe Fesoterodine Market Size (2014-2019)
    • 6.2 Fesoterodine Key Players in Europe
    • 6.3 Europe Fesoterodine Market Size by Type
    • 6.4 Europe Fesoterodine Market Size by Application

    7 China

    • 7.1 China Fesoterodine Market Size (2014-2019)
    • 7.2 Fesoterodine Key Players in China
    • 7.3 China Fesoterodine Market Size by Type
    • 7.4 China Fesoterodine Market Size by Application

    8 Japan

    • 8.1 Japan Fesoterodine Market Size (2014-2019)
    • 8.2 Fesoterodine Key Players in Japan
    • 8.3 Japan Fesoterodine Market Size by Type
    • 8.4 Japan Fesoterodine Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Fesoterodine Market Size (2014-2019)
    • 9.2 Fesoterodine Key Players in Southeast Asia
    • 9.3 Southeast Asia Fesoterodine Market Size by Type
    • 9.4 Southeast Asia Fesoterodine Market Size by Application

    10 India

    • 10.1 India Fesoterodine Market Size (2014-2019)
    • 10.2 Fesoterodine Key Players in India
    • 10.3 India Fesoterodine Market Size by Type
    • 10.4 India Fesoterodine Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Fesoterodine Market Size (2014-2019)
    • 11.2 Fesoterodine Key Players in Central & South America
    • 11.3 Central & South America Fesoterodine Market Size by Type
    • 11.4 Central & South America Fesoterodine Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Fesoterodine Introduction
      • 12.1.4 Pfizer Revenue in Fesoterodine Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 Amerigen Pharmaceuticals
      • 12.2.1 Amerigen Pharmaceuticals Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Fesoterodine Introduction
      • 12.2.4 Amerigen Pharmaceuticals Revenue in Fesoterodine Business (2014-2019)
      • 12.2.5 Amerigen Pharmaceuticals Recent Development
    • 12.3 SANDOZ
      • 12.3.1 SANDOZ Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Fesoterodine Introduction
      • 12.3.4 SANDOZ Revenue in Fesoterodine Business (2014-2019)
      • 12.3.5 SANDOZ Recent Development
    • 12.4 LUPIN
      • 12.4.1 LUPIN Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Fesoterodine Introduction
      • 12.4.4 LUPIN Revenue in Fesoterodine Business (2014-2019)
      • 12.4.5 LUPIN Recent Development
    • 12.5 Dr. Reddy's Laboratories
      • 12.5.1 Dr. Reddy's Laboratories Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Fesoterodine Introduction
      • 12.5.4 Dr. Reddy's Laboratories Revenue in Fesoterodine Business (2014-2019)
      • 12.5.5 Dr. Reddy's Laboratories Recent Development
    • 12.6 Lupin
      • 12.6.1 Lupin Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Fesoterodine Introduction
      • 12.6.4 Lupin Revenue in Fesoterodine Business (2014-2019)
      • 12.6.5 Lupin Recent Development
    • 12.7 Amneal Pharmaceuticals
      • 12.7.1 Amneal Pharmaceuticals Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Fesoterodine Introduction
      • 12.7.4 Amneal Pharmaceuticals Revenue in Fesoterodine Business (2014-2019)
      • 12.7.5 Amneal Pharmaceuticals Recent Development
    • 12.8 Aurobindo Pharma
      • 12.8.1 Aurobindo Pharma Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Fesoterodine Introduction
      • 12.8.4 Aurobindo Pharma Revenue in Fesoterodine Business (2014-2019)
      • 12.8.5 Aurobindo Pharma Recent Development
    • 12.9 Sun Pharmaceutical
      • 12.9.1 Sun Pharmaceutical Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Fesoterodine Introduction
      • 12.9.4 Sun Pharmaceutical Revenue in Fesoterodine Business (2014-2019)
      • 12.9.5 Sun Pharmaceutical Recent Development
    • 12.10 Accord Healthcare
      • 12.10.1 Accord Healthcare Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Fesoterodine Introduction
      • 12.10.4 Accord Healthcare Revenue in Fesoterodine Business (2014-2019)
      • 12.10.5 Accord Healthcare Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Fesoterodine (INN, used as the fumarate under the brand name Toviaz) is an antimuscarinic drug developed by Schwarz Pharma AG to treat overactive bladder syndrome (OAB).
      In 2018, the global Fesoterodine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Fesoterodine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Fesoterodine development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      Amerigen Pharmaceuticals
      SANDOZ
      LUPIN
      Dr. Reddy's Laboratories
      Lupin
      Amneal Pharmaceuticals
      Aurobindo Pharma
      Sun Pharmaceutical
      Accord Healthcare

      Market segment by Type, the product can be split into
      4 mg Tablet
      8 mg Tablet

      Market segment by Application, split into
      Hospital
      Drug store

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Fesoterodine status, future forecast, growth opportunity, key market and key players.
      To present the Fesoterodine development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Fesoterodine are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now